151 related articles for article (PubMed ID: 31331930)
1. Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition.
Yu M; Graham K; Pasalic L; Alahakoon TI
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31331930
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
3. Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss.
Mohd Nazri H; Noor Haslina MN; Shafini MY; Noor Shaidatul Akmal AR; Rapiaah M; Wan Zaidah A
Malays J Pathol; 2017 Apr; 39(1):73-76. PubMed ID: 28413208
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of fetal erythroblastosis due to anti-M alloimmunization with fetal intravascular transfusion.
Seo MW; Won HS; Kim SK; Shim JY; Kwon SW; Lee PR; Kim A
Prenat Diagn; 2007 Apr; 27(4):385-7. PubMed ID: 17393557
[No Abstract] [Full Text] [Related]
5. Hydrops fetalis with isolated massive ascites in a preterm neonate with rhesus disease.
Nourkami-Tutdibi N; Geipel M; Meyberg-Solomayer G; Takacs Z; Meyer S
Wien Med Wochenschr; 2022 Oct; 172(13-14):290-291. PubMed ID: 33738630
[TBL] [Abstract][Full Text] [Related]
6. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
[TBL] [Abstract][Full Text] [Related]
7. A severe transfusion-dependent congenital dyserythropoietic anaemia presenting as hydrops fetalis.
Cantù-Rajnoldi A; Zanella A; Conter U; Faccini P; Soligo D; Gornati G; Vegni C; Nicolini U
Br J Haematol; 1997 Mar; 96(3):530-3. PubMed ID: 9054660
[TBL] [Abstract][Full Text] [Related]
8. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
9. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.
Ziprin JH; Payne E; Hamidi L; Roberts I; Regan F
Transfus Med; 2005 Feb; 15(1):57-60. PubMed ID: 15713130
[TBL] [Abstract][Full Text] [Related]
10. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
11. A case for comprehensive antenatal screening for blood group antibodies.
Anwar M; Ali N; Khattak MF; Raashid Y; Karamat KA
J Pak Med Assoc; 1999 Oct; 49(10):246-8. PubMed ID: 10647230
[TBL] [Abstract][Full Text] [Related]
12. [Hemolytic disease of the newborn due to anti-Kidd Jka sensitization during pregnancy].
Mizutani T; Tanizawa O; Imai S; Suehara N; Takemura T; Wada Y; Fujita T; Kidoguchi K; Nakayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1587-90. PubMed ID: 2584811
[No Abstract] [Full Text] [Related]
13. Severe fetal hydrops resulting from ABO incompatibility.
Sherer DM; Abramowicz JS; Ryan RM; Sheils LA; Blumberg N; Woods JR
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):897-9. PubMed ID: 1923220
[TBL] [Abstract][Full Text] [Related]
14. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
15. Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature.
Di Ciaccio P; Cutts B; Alahakoon TI; Dennington PM; Soo LA; Curnow J
Vox Sang; 2021 May; 116(5):591-600. PubMed ID: 33326620
[TBL] [Abstract][Full Text] [Related]
16. Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk.
Li M; Blaustein JC
Transfusion; 2017 Sep; 57(9):2121-2124. PubMed ID: 28580721
[TBL] [Abstract][Full Text] [Related]
17. A case of severe hemolytic disease of the newborn due to anti-Verweyst (Vw).
Taylor AM; Knighton GJ
Transfusion; 1982; 22(2):165-6. PubMed ID: 7071922
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation.
Hyland CA; O'Brien H; Flower RL; Gardener GJ
Transfus Apher Sci; 2020 Oct; 59(5):102947. PubMed ID: 33115620
[TBL] [Abstract][Full Text] [Related]
19. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
20. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
